Predictions
Tonix Pharmaceuticals Holding Corp.
Start price
Target price
Perf. (%)
€11.58
29.07.22
29.07.22
-
29.07.23
29.07.23
-15.51%
06.08.22
06.08.22
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€4.11
28.07.22
28.07.22
-
28.07.23
28.07.23
35.16%
14.05.23
14.05.23
Nanorepro AG
Start price
Target price
Perf. (%)
€3.97
27.07.22
27.07.22
€15.00
27.08.22
27.08.22
-14.12%
28.08.22
28.08.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Very high dividend yield expected
Top 10 in its market
Tonix Pharmaceuticals Holding Corp.
Start price
Target price
Perf. (%)
€11.02
26.07.22
26.07.22
-
26.07.23
26.07.23
-70.93%
09.04.23
09.04.23
Tonix Pharmaceuticals Holding Corp.
Start price
Target price
Perf. (%)
€8.77
25.07.22
25.07.22
-
25.07.23
25.07.23
11.60%
07.08.22
07.08.22
Syndax Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€20.60
25.07.22
25.07.22
-
25.07.23
25.07.23
-7.28%
26.07.23
26.07.23
Could be worthwhile Investment >10% per year
B.R.A.I.N. Biotechnology Research and Information Network AG
Start price
Target price
Perf. (%)
€7.52
25.07.22
25.07.22
-
21.03.23
21.03.23
-16.22%
22.03.23
22.03.23
Tonix Pharmaceuticals Holding Corp.
Start price
Target price
Perf. (%)
€8.56
25.07.22
25.07.22
€12.50
25.07.23
25.07.23
26.95%
26.07.22
26.07.22
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Little innovation
Kezar Life Sciences
Start price
Target price
Perf. (%)
€9.55
25.07.22
25.07.22
€20.00
31.12.24
31.12.24
-75.71%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.16
24.07.22
24.07.22
-
24.07.23
24.07.23
-2.64%
04.09.22
04.09.22
Valneva SE
Start price
Target price
Perf. (%)
€9.82
21.07.22
21.07.22
-
21.07.23
21.07.23
-30.16%
22.07.23
22.07.23
Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.37
21.07.22
21.07.22
€5.30
21.07.23
21.07.23
-21.42%
11.03.23
11.03.23
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
CytoDyn Inc_INT
Start price
Target price
Perf. (%)
€0.65
21.07.22
21.07.22
€0.60
21.07.23
21.07.23
-46.97%
19.11.22
19.11.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
Evofem Biosciences Inc.
Start price
Target price
Perf. (%)
€0.99
21.07.22
21.07.22
-
21.07.23
21.07.23
-53.25%
14.05.23
14.05.23
Pfizer Inc.
Start price
Target price
Perf. (%)
€49.74
20.07.22
20.07.22
€55.00
20.07.23
20.07.23
-33.55%
21.07.23
21.07.23
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques